CeMIA SA is a spinoff company from the Department of Immunology & Histocompatibility, Faculty of Medicine, University of Thessaly, Greece.

It received funding for its instigation under the action “Creation-support of new innovative knowledge intensive firms” of the Operational Program “Competitiveness and Entrepreneurship” in 2011.

CeMIA capitalizes on the results of the research activities of the University of Thessaly.

It aims to fill a major gap in the Greek and South Eastern European market of cellular and molecular immunobiological services.